Regenxbio
RGNX
RGNX
174 hedge funds and large institutions have $705M invested in Regenxbio in 2023 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 60 increasing their positions, 66 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
9% less capital invested
Capital invested by funds: $778M → $705M (-$72.6M)
25% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 24
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
174
Holding in Top 10
1
Calls
$1.51M
Puts
$761K
Top Buyers
| 1 | +$25.6M | |
| 2 | +$13.2M | |
| 3 | +$11.4M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$7.1M |
| 5 |
MFS
Mirabella Financial Services
London,
United Kingdom
|
+$5.46M |
Top Sellers
| 1 | -$41.9M | |
| 2 | -$5.16M | |
| 3 | -$4.06M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$3.01M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$2.94M |